The current mono phase 3 trial is an investigation
Post# of 145464
![](/assets/46931549/no_avatar_available_thumb.jpg)
Nader says he's going to push out the start date of the new mono trial. I think that's a strategic mistake. A lot of our R&D cost is associated with the current Phase 3 and extension. By starting the new trial and doing a slow ramp up of patient induction and ending the old trial we can reduce monthly R&D expense. It's best to start the new trial after approval in HIV so patients in our current trial can have uninterrupted access to leronlimab.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)